Vivoryon Therapeutics AG to Publish its Full Year 2019 Results on March 26, 2020

On March 19, 2020 Vivoryon Therapeutics AG (Euronext Amsterdam: VVY, ISIN DE0007921835), reported that it will publish its Full Year Results for 2019 on Thursday, March 26, 2020 (Press release, Vivoryon Therapeutics, MAR 19, 2020, View Source [SID1234555688]). The company will host a conference call and webcast (in English) open to the public. The Full Year 2019 Results will be available to download on the company website (www.vivoryon.com/investors-news/financial-information/)

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference call details

Date: Thursday, March 26, 2020
Time: 3:00 pm CET /10:00 am EDT

Access Code: 68603233#

From Germany: +49 69 201 744 220
From UK: +44 203 009 2470
From USA: +1 877 423 0830

Webcast details

A live webcast and slides will be made available at: (www.vivoryon.com/investors-news/financial-information/)